Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [519]
News [399]
Articles [53]
Editorials [2]
Conferences [79]
elearning [8]
Editor's Choice for January 2017
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for January 2017 ( Prof Gordon McVie - Editor in Chief, ecancer )
2 Feb 2017
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016
ASH 2016 highlights: breaking new ground in haematology
Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy
ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )
6 Dec 2016
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML...
Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients ( Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016
How can we use crenolanib to treat AML?
Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA
How can we use crenolanib to treat AML? ( Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA )
5 Dec 2016
Vosaroxin for relapsed AML: Updates from VALOR
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
Vosaroxin for relapsed AML: Updates from VALOR ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Venetoclax plus cytarabine in elderly AML patients
Dr Andrew Wei - Alfred Hospital, Melbourne, Australia
Venetoclax plus cytarabine in elderly AML patients ( Dr Andrew Wei - Alfred Hospital, Melbourne, Australia )
4 Dec 2016
Subgroup analysis of elderly high risk AML patients receiving CPX-351
Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
Subgroup analysis of elderly high risk AML patients receiving CPX-351 ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
3 Dec 2016
Distress among older cancer patients
Dr Armin Shahrokni - Memorial Sloan Kettering Cancer Center, New York, USA
Distress among older cancer patients ( Dr Armin Shahrokni - Memorial Sloan Kettering Cancer Center, New York, USA )
22 Nov 2016
The successes of SIOG and geriatric patient advocacy
Dr Etienne Brain - Institut Curie, Paris, France
The successes of SIOG and geriatric patient advocacy ( Dr Etienne Brain - Institut Curie, Paris, France )
22 Nov 2016
Geriatric assessment: next big challenges
Dr Marije Hamaker - Diakonessenhuis, Utrecht, Netherlands
Geriatric assessment: next big challenges ( Dr Marije Hamaker - Diakonessenhuis, Utrecht, Netherlands )
22 Nov 2016
Exercise, neurodegeneration and prostate cancer
Dr Shabbir Alibhai - Princess Margaret Cancer Centre, Toronto, Canada
Exercise, neurodegeneration and prostate cancer ( Dr Shabbir Alibhai - Princess Margaret Cancer Centre, Toronto, Canada )
22 Nov 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation